Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Chemnitz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Innere Medizin (Heidelberg, Germany)|September 4, 2025
[Rare cause of pure white cell aplasia (PWCA) in a 76-year-old male patient]Milven Klka, Evita Bothur, Meike Clemens, et al.
American Journal of Hematology|September 28, 2002
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabJens Chemnitz, Andreas Draube, Christof Scheid, et al.
Blood|March 9, 2006
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibitionMichael S von Bergwelt-Baildon, Alexey Popov, Tomo Saric, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Blood Advances|July 1, 2021
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomasNora Liebers, Johannes Duell, Donnacha Fitzgerald, et al.
Blood Cancer Journal|October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemiaChristina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Innere Medizin (Heidelberg, Germany)|September 4, 2025
[Rare cause of pure white cell aplasia (PWCA) in a 76-year-old male patient]Milven Klka, Evita Bothur, Meike Clemens, et al.
American Journal of Hematology|September 28, 2002
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabJens Chemnitz, Andreas Draube, Christof Scheid, et al.
Blood|March 9, 2006
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibitionMichael S von Bergwelt-Baildon, Alexey Popov, Tomo Saric, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Blood Advances|July 1, 2021
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomasNora Liebers, Johannes Duell, Donnacha Fitzgerald, et al.
Blood Cancer Journal|October 5, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemiaChristina Rautenberg, Friedrich Stölzel, Christoph Röllig, et al.
Pageof 1